Status:
COMPLETED
Imaging Study of Chronic Low Back Pain in Patients Taking Pain Medication
Lead Sponsor:
Stanford University
Conditions:
Low Back Pain
Eligibility:
MALE
18-60 years
Phase:
NA
Brief Summary
Duloxetine has recently been shown to be effective in reducing the pain in chronic pain patients. Duloxetine is known to exert a central mechanism, however the precise human brain structures responsib...
Eligibility Criteria
Inclusion
- Males aged 18-60
- Back Pain
- Must be able to comply with study visit schedule and other study requirements
- Capable of performing the experimental tasks
Exclusion
- Contraindications for MRI examination (e.g., metallic implants such as pacemakers, surgical aneurysm clips, or known metal fragments embedded in the body)
- Known hypersensitivity to duloxetine or any of the inactive ingredients
- Uncontrolled narrow-angle glaucoma
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00388414
Start Date
September 1 2006
End Date
January 1 2010
Last Update
December 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305